Buy Kpv Peptide For Research

Sourcing High-Purity KPV Peptide for Laboratory Research

When principal investigators seek to buy KPV peptide for research, securing high-purity, fully verified analytical reagents is critical for experimental reproducibility. KPV (Lysine-Proline-Valine) is an anti-inflammatory tripeptide derived from the C-terminal sequence of alpha-melanocyte-stimulating hormone (alpha-MSH). PX1 Research supplies synthesized KPV tripeptide strictly reserved for in vitro cellular assays, biochemical evaluations, and preclinical animal models.

To ensure reliable data across cellular and animal experiments, PX1 Research manufactures all compounds within domestic USA facilities operating under strict Quality Management Systems. Every batch is validated by an independent ISO 17025 accredited laboratory using reverse-phase high-performance liquid chromatography (RP-HPLC) and liquid chromatography-mass spectrometry (LC-MS). Lab managers can access lot-specific Certificates of Analysis (COAs) directly through our research catalog to review precise purity percentages, mass verification spectra, and endotoxin assay results before initiating experimental protocols.

Molecular Architecture and Biochemical Properties of Lys-Pro-Val

KPV is a tripeptide composed of the amino acid sequence L-Lysine-L-Proline-L-Valine. It corresponds to residues 11–13 of the endogenous 13-amino-acid peptide alpha-melanocyte-stimulating hormone (alpha-MSH). While parent alpha-MSH exerts systemic endocrine effects and interacts strongly with melanocortin receptors (MC1R through MC5R), the truncated C-terminal tripeptide KPV displays distinct pharmacodynamic properties.

Preclinical studies indicate that KPV retains the core anti-inflammatory properties of alpha-MSH without stimulating melanogenesis or activating central nervous system melanocortin receptors to the same degree as full-length melanocortin agonists. This functional dissociation makes KPV a valuable target in molecular biology for isolating anti-inflammatory pathways from pigmentary or metabolic signaling cascades. Molecular weight verification by mass spectrometry typically yields a single sharp ion peak corresponding to the monoisotopic mass of the Lys-Pro-Val structure, confirming the absence of truncated sequences or amino acid deletions.

Cellular Signaling and Anti-Inflammatory Mechanisms

In vitro data indicate that KPV modulates intracellular signaling cascades involved in the acute and chronic inflammatory response. The primary mechanism identified in cell culture models involves the inhibition of Nuclear Factor kappa B (NF-kB) translocation. NF-kB is a master transcriptional regulator responsible for upregulating pro-inflammatory cytokines, chemokines, and cell adhesion molecules.

When laboratory models of inflammation (such as lipopolysaccharide-stimulated RAW 264.7 macrophages or human intestinal epithelial cell lines) are treated with KPV, researchers observe a marked reduction in NF-kB activation. This nuclear blockade subsequently downregulates downstream inflammatory mediators, including interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), and interleukin-1 beta (IL-1beta). Additionally, KPV enters cells via peptide transporter 1 (PepT1/SLC15A1), an apical membrane transporter expressed heavily in intestinal epithelia. Once internalized, KPV interacts directly with intracellular targets to suppress inflammatory signaling independent of classical cell-surface melanocortin receptor activation.

Preclinical Findings in Intestinal Inflammation and Mucosal Barrier Models

The primary focus of active literature on KPV centers on gastrointestinal pathophysiology and mucosal barrier restoration. Rodent models of colitis—such as those induced by dextran sulfate sodium (DSS) or 2,4,6-trinitrobenzenesulfonic acid (TNBS)—have demonstrated that KPV administration reduces histological inflammation, attenuates colonic shortening, and decreases local cytokine expression.

In vitro barrier assays utilizing Caco-2 cell monolayers show that KPV preserves tight junction integrity during inflammatory challenge. Exposure to pro-inflammatory cytokines normally causes transmembrane protein disruption, leading to increased transepithelial electrical resistance (TEER) loss and hyperpermeability. Preclinical studies suggest that KPV treatment preserves the expression and localization of crucial tight junction proteins, including zonula occludens-1 (ZO-1) and occludin. Consequently, investigators studying inflammatory bowel disease (IBD) mechanisms frequently select the KPV peptide product to probe intestinal epithelial repair pathways.

Comparing KPV with Related Cytoprotective and Inflammatory Modulators

When evaluating candidates for anti-inflammatory or tissue repair research, investigators often compare KPV to other well-characterized regulatory peptides. While KPV functions primarily via PepT1 entry and NF-kB suppression, alternative peptides operate through complementary cellular pathways.

For example, researchers studying gut mucosal healing frequently compare KPV alongside BPC-157, a pentadecapeptide known for modulating VEGFR2 signaling and focal adhesion kinase activation. In antimicrobial and innate immune response assays, scientists often evaluate KPV in tandem with LL-37, a cathelicidin host defense peptide that acts directly on bacterial cell membranes while modulating toll-like receptor (TLR) pathways. For broader systemic melanocortin receptor investigations, labs often baseline KPV performance against alpha-MSH structural analogs. Understanding these distinct biochemical pathways allows researchers to design multi-target comparative studies using our full research peptide library.

Quality Assurance: HPLC, LC-MS, and Endotoxin Testing Standards

The validity of preclinical data depends entirely on the chemical purity and consistency of the underlying reagents. Impurities such as residual coupling agents, organic solvents, or TFA salts can introduce cytotoxicity or confound cell culture assays. When researchers choose to buy KPV peptide for research from PX1 Research, they receive materials that have undergone rigorous analytical clearance.

Every batch is evaluated via high-performance liquid chromatography (RP-HPLC) to verify a chemical purity profile of 98.0% or higher. Mass spectrometry (LC-MS) confirms exact molecular mass and sequence fidelity. Furthermore, because KPV is frequently applied to cellular cultures sensitive to bacterial contaminants, PX1 Research performs quantitative Chromogenic LAL (Limulus Amebocyte Lysate) assays on every lot. We maintain strict endotoxin limits (<0.01 EU/mg), ensuring that observed anti-inflammatory effects are not obscured by bacterial endotoxin contamination.

Laboratory Storage, Solubility, and Reconstitution Guidelines

KPV is supplied as a lyophilized (freeze-dried) powder to maximize long-term chemical stability. To maintain reagent integrity within the laboratory environment, strict storage and reconstitution protocols must be followed:

Upon arrival, un-reconstituted lyophilized KPV vials should be stored at -20°C for short-to-medium term storage, or at -80°C for long-term preservation, protected from ambient light and moisture. Prior to reconstitution, vials should be allowed to equilibrate to room temperature inside a desiccator to prevent atmospheric moisture condensation on the cake.

Reconstitution should be performed inside a laminar flow bio-safety cabinet using sterile laboratory-grade solvents. KPV is freely soluble in sterile bacteriostatic water, sterile phosphate-buffered saline (PBS, pH 7.4), or standard cell culture media. After reconstitution, stock solutions should be aliquoted into single-use polypropylene microtubes and stored at -20°C or -80°C to avoid repeated freeze-thaw cycles, which can cause peptide degradation over time.

Experimental Methodologies and In Vitro Assay Applications

In vitro experimental designs utilizing KPV typically focus on transport kinetics, cytokine profiling, and gene expression analysis. In PepT1 transport studies, KPV is added to apical chambers of Transwell-cultured epithelial sheets to quantify transport velocity and cellular uptake mechanisms.

In macrophage activation protocols, RAW 264.7 cells are pre-treated with KPV concentrations ranging from sub-micromolar to micromolar ranges prior to LPS stimulation. Supernatants are subsequently analyzed via ELISA or multiplex bead assays to measure TNF-alpha and IL-6 suppression, while cell lysates are harvested for Western blot analysis of phosphorylated NF-kB p65 subunits. Institutional investigators conducting large-scale screening assays can coordinate volume sourcing through our dedicated wholesale laboratory program.

Why Laboratory Investigators Source KPV from PX1 Research

PX1 Research serves as a trusted domestic partner for university laboratories, biotechnology enterprises, and contract research organizations (CROs). We understand that reproducible science requires absolute transparency in supplier quality control.

All products ship directly from our state-of-the-art fulfillment facilities in California and Arizona. Orders placed Monday through Friday before 12:00 PM PST feature same-day dispatch, minimizing transit time and thermal degradation risk. Every order includes complete lot traceability, direct COA access, and dedicated technical support to assist lab managers in verifying reagent specifications.